UCSF, UCLA gain FDA approval for prostate cancer imaging technique
The University of California’s two nationally ranked medical centers, UC San Francisco and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated.
Source: Duane Bates,Elizabeth Fernandez - UCSF.edu